Trevena Inc (NAS:TRVN)
$ 6.7 -0.79 (-10.55%) Market Cap: 5.71 Mil Enterprise Value: 26.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q3 2020 Trevena Inc Earnings Call Transcript

Nov 02, 2020 / 01:30PM GMT
Release Date Price: $1681.25 (+2.67%)
Operator

Greetings. Welcome to the Trevena Conference Call to provide an update on commercial launch activities for OLINVYK. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, Chief Financial Officer, Barry Shin. You may begin.

Barry Shin
Trevena, Inc. - Senior VP & CFO

Good morning, and welcome, everyone. With me today are Carrie Bourdow, our President and CEO; Bob Yoder, our Chief Commercial Officer; and our Chief Medical Officer, Mark Demitrack.

As a reminder, we'll be making forward looking statements within the meaning of federal securities law. These statements are subject to risks and uncertainties related to our business, including those covered in our filings with the SEC. We undertake no obligations to update these statements beyond today.

During today's call, Carrie will open with introductory remarks and Bob will provide an update on our ongoing launch activities for OLINVYK, which is approved in adults for the management of acute pain severe enough to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot